Celldex Therapeutics, Inc. (CLDX)
$40.57+0.47%Close
BUYBULL · day 41
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.7B
- Avg volume
- 962.6K
- Beta
- 0.84
- P/E (TTM)
- -9.31
- Short % float
- 12.43%
- Days to cover
- 7.6
- SI change
- -0.5%
- 1W
- -3.22%
- 1M
- +14.99%
- 3M
- +32.02%
- YTD
- +50.20%
- vs SPY 1W
- -2.03%
- vs SPY 1M
- +11.67%
- vs SPY 3M
- +29.63%
- vs SPY YTD
- +38.45%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
- SYREBUYSpyre Therapeutics, Inc.$9.2BBULLQ 11$106.49+0.15%
- ABCLBUYAbCellera Biologics Inc.$3.5BRECOVERYQ -7$11.32-6.27%
- QUREBUYuniQure N.V.$3.4BRECOVERYQ 20$48.37-1.88%
- IMNMBUYImmunome, Inc.$2.7BBULLQ 22$28.52-1.79%
- NUVBBUYNuvation Bio Inc.$2.4BRECOVERYQ 7$6.93-2.45%
- VERASELLVera Therapeutics, Inc.$2.3BRECOVERYQ 23$32.27+4.49%
- HRMYBUYHarmony Biosciences Holdings, Inc.$2.2BBULLQ 0$38.15+0.92%
- BHVNSELLBiohaven Ltd.$2.1BCRISISQ 19$13.85-1.23%
- JANXBUYJanux Therapeutics, Inc.$1.1BRECOVERYQ 12$17.39+6.96%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 3
- GROWTH
- 4
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-31.4%
REV YoY-
ROE-52.4%
EPS YoY-
ROA-38.4%
GROSS-56851
OP-290948
NET-268386
[VALUATION]
P/E TTM-9.31
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B4.42
P/FCF-
EV/EBITDA-8.94
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.69
ALTMAN Z-
CURR RATIO11.82
ND/EBITDA-
BETA0.84
